Latest Matter News

Innovaero has reported A$3.6 million of first-quarter revenue and A$42.9 million in cash in its first post-listing quarterly update. Its core OWL-B program remains on track for Australian Defence Force certification in March 2027, but any customer order remains conditional on that milestone.

The Takeovers Panel has declined to examine a challenge to Zenith Minerals’ handling of Aurenne’s proposed $5 million funding, removing one regulatory obstacle to Forrestania Resources’ recommended takeover. The Panel said there was no reasonable prospect of declaring unacceptable circumstances, but detailed reasons are still to come.

Objective Corporation delivered 9% revenue growth and a 5% lift in net profit for FY2026, but the loss of a long-running Defence agreement and a separate NHVR contract will pressure recurring revenue in the year ahead. Management expects adjusted EBITDA of at least $40 million in FY2027 as it keeps investing in AI, sales capacity and potential acquisitions.

Bannerman Energy and CNNC Overseas have approved the Final Investment Decision for the Etango uranium project in Namibia, clearing the way for full-scale construction and targeting first yellowcake in 2028. The project is forecast to produce about 3.5 million pounds of U3O8 annually, with construction funding described as covered by existing cash balances.

MaxiPARTS has delivered a sharp lift in first-quarter operating profit despite modest revenue growth, while its newly acquired Air Brake Systems business is set to contribute for most of FY27. The company has reiterated expectations for further earnings improvement and increased capital returns.

Swoop Holdings has agreed to sell its Sydney-based Fibre assets to Xenith for approximately $4.5 million, extending a portfolio simplification drive aimed at reducing debt. Completion remains subject to FIRB approval and other conditions, with settlement expected in Q3 FY27.

X2M Connect has secured 60-day exclusivity over a Queensland site for a planned 10MW AI-enabled data centre, with development approval and 2.5MW of grid capacity already in place. The estimated $250 million project could add delivery revenue, recurring platform fees and a potential token revenue share, but key commercial terms remain unresolved.

Paradigm’s administrators have asked the Supreme Court of Western Australia for up to three more months to assess sale and recapitalisation proposals. Without the extension, they say they would have no alternative but to recommend winding up the biotech.

Hawthorn Resources is nearing a financial investment decision on a larger Anglo-Saxon open pit after upgrading the project’s resource to about 200,000 ounces. The opportunity is advancing alongside a wider FY2026 loss, falling cash and pending exploration results at Pinjin East.

Fenix Resources has monetised most of its iron ore swap book for more than A$10 million, converting protection on 480,000 tonnes into near-term cash. The move leaves the company retaining diesel and currency hedges while restoring exposure to prevailing iron ore prices on the settled tonnes.

Arovella has released two clinical batches of its off-the-shelf CAR-iNKT therapy, activated two trial sites and begun screening patients ahead of expected first dosing in October. The biotech ended September with A$11.6 million in cash, rising to about A$15.63 million pro forma after an R&D rebate.

Zip delivered strong first-quarter growth, with total transaction volume up 18% to A$4.6 billion, but a US fraud event cost A$10.1 million and pushed group net bad debts higher. The company nevertheless reaffirmed its A$340 million FY27 cash EBTDA target, with September momentum offering an early test of whether the disruption was temporary.